COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

March 06, 2025



« back to news page